| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TSBP1 and BTNL2 antisense RNA 1 | 0.638 | 0.692 |
|
disease | 0.100 | None | 1.000 | 6 | 221 | 2007 | 2014 | |||||||||
|
testis expressed basic protein 1 | 0.638 | 0.692 | 1.5E-16 |
|
disease | 0.130 | None | 0.889 | 9 | 149 | 2007 | 2019 | ||||||||
|
major histocompatibility complex, class II, DP beta 1 | 0.453 | 0.923 | 5.3E-10 |
|
disease | 0.500 | None | 0.938 | 32 | 62 | 1988 | 2020 | ||||||||
|
cytochrome P450 family 21 subfamily A member 2 | 0.525 | 0.769 | 2.6E-04 |
|
disease | 0.100 | None | 1.000 | 3 | 46 | 2007 | 2011 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.200 | None | 1.000 | 16 | 45 | 1982 | 2018 | ||||||||
|
major histocompatibility complex, class II, DR alpha | 0.581 | 0.769 | 0.52 |
|
disease | 0.100 | None | 1.000 | 3 | 36 | 2007 | 2011 | ||||||||
|
butyrophilin like 2 | 0.546 | 0.808 | 8.6E-11 |
|
disease | 0.120 | None | 1.000 | 6 | 31 | 2005 | 2013 | ||||||||
|
notch receptor 4 | 0.534 | 0.731 | 2.1E-23 |
|
disease | 0.150 | None | 1.000 | 8 | 25 | 2001 | 2013 | ||||||||
|
tenascin XB | 0.572 | 0.731 | 1.9E-02 |
|
disease | 0.110 | None | 1.000 | 4 | 23 | 2001 | 2011 | ||||||||
|
major histocompatibility complex, class II, DR beta 9 (pseudogene) | 0.682 | 0.654 |
|
disease | 0.100 | None | 1.000 | 6 | 21 | 2007 | 2019 | |||||||||
|
proline rich coiled-coil 2A | 0.656 | 0.654 | 1.00 |
|
disease | 0.130 | None | 1.000 | 6 | 15 | 1998 | 2011 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 2 | 0.617 | 0.769 | 1.0E-05 |
|
disease | 0.400 | None | 1.000 | 4 | 15 | 2007 | 2011 | ||||||||
|
major histocompatibility complex, class I, C | 0.415 | 0.846 | 1.6E-06 |
|
disease | 0.200 | None | 0.944 | 18 | 14 | 1993 | 2019 | ||||||||
|
complement C2 | 0.617 | 0.692 | 1.3E-16 |
|
disease | 0.120 | None | 1.000 | 5 | 13 | 1976 | 2011 | ||||||||
|
BAG cochaperone 6 | 0.674 | 0.615 | 1.00 |
|
disease | 0.100 | None | 1.000 | 3 | 12 | 2007 | 2011 | ||||||||
|
AP4B1 antisense RNA 1 | 0.805 | 0.231 |
|
disease | 0.100 | None | 1.000 | 2 | 12 | 2009 | 2019 | |||||||||
|
major histocompatibility complex, class II, DO alpha | 0.509 | 0.808 | 3.0E-10 |
|
disease | 0.140 | None | 1.000 | 7 | 11 | 1986 | 2016 | ||||||||
|
psoriasis susceptibility 1 candidate 1 | 0.656 | 0.731 | 2.7E-04 |
|
disease | 0.130 | None | 1.000 | 5 | 11 | 2007 | 2017 | ||||||||
|
major histocompatibility complex, class II, DQ beta 3 | 0.931 | 0.192 |
|
disease | 0.100 | None | 1.000 | 1 | 11 | 2011 | 2011 | |||||||||
|
peptidyl arginine deiminase 4 | 0.494 | 0.808 | 4.6E-16 |
|
disease | 0.500 | None | 0.912 | 125 | 10 | 2003 | 2020 | ||||||||
|
MSH5-SAPCD1 readthrough (NMD candidate) | 0.760 | 0.423 |
|
disease | 0.100 | None | 1.000 | 3 | 10 | 2007 | 2011 | |||||||||
|
mutS homolog 5 | 0.641 | 0.692 | 3.2E-11 |
|
disease | 0.100 | None | 1.000 | 3 | 10 | 2007 | 2011 | ||||||||
|
ubiquinol-cytochrome c reductase complex assembly factor 2 | 0.705 | 0.462 | 1.9E-02 |
|
disease | 0.100 | None | 1.000 | 3 | 10 | 2007 | 2011 | ||||||||
|
1-acylglycerol-3-phosphate O-acyltransferase 1 | 0.743 | 0.423 | 0.97 |
|
disease | 0.100 | None | 1.000 | 1 | 10 | 2011 | 2011 | ||||||||
|
signal transducer and activator of transcription 4 | 0.471 | 0.769 | 0.77 |
|
disease | 0.500 | None | 0.889 | 63 | 9 | 2000 | 2019 |